Reduced financial toxicity and reduced health care spending, with similar treatment effectiveness through efficient, scalable interventions within the electronic health record.
We apply the latest science to create, test, and scale solutions to address the most intractable problems in cancer care delivery.
We are worldwide experts in employing financial and non-financial interventions to nudge patient and clinician behavior in cancer care, informed by lessons from health economics and behavioral economics.
Use of Social Incentives to Change Behaviors, Improve Ambulation and Health Outcomes After Major Abdominal Surgeries for Cancer
We are performing a trial and evaluation of social incentives to improve ambulation and health outcomes after major abdominal surgeries, such as radical cystectomy.
We are collaborating with the Penn Medicine Health Care Innovation Center to develop and evaluate an AI-augmented Conversational Agent -- also known as a chat bot -- to enhance oral chemotherapy adherence.
Effect of a National Pay-for-Performance Program for Oncology on Use of Evidence-Based Cancer Drug Regimens and Spending
Our objective is to evaluate the association between a national insurer’s pay-for-performance (P4P) program for oncology and changes in prescribing of evidence-based cancer drugs and spending.
We found that a simple "nudge" dramatically decreased low-value cancer care for patients with advanced cancer receiving palliative radiation.